Austin, TX 12/10/2007 11:26:22 PM
News / Finance

Speak with other shareholders about: (OTCBB: NMKT), (OTCBB: IDOI) and (OTCBB: SFSH).

Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the Chat Live button at the top.

----------------------------------------------------------
    
Chat real-time with other investors about this NMKT news release,
by clicking this link: http://www.stockwire.com/NMKT

To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=NMKT

NewMarket Technology, Inc. (OTCBB: NMKT) up 16.9% on 1.6 million shares traded.

NewMarket helps clients maintain the delicate balance between maintaining legacy systems and gaining a competitive edge from the latest technology innovations. NewMarket provides certified integration and maintenance services to support the prevailing industry standard solutions such as Microsoft, Cisco Systems, SAP, Siebel and Sun Microsystems. On Dec. 7th 2007, the company released a statement from Major General (Ret.) Hugh Robinson, NewMarket Board Member and Former Chairman of the Federal Reserve Bank of Dallas, in conjunction with the $7 million strategic financing transaction the Company announced yesterday.

----------------------------------------------------------
    
Chat real-time with other investors about this IDOI news release,
by clicking this link: http://www.stockwire.com/IDOI

To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=IDOI

IDO Security Inc., (OTCBB: IDOI) up 11.1% on 141,000 shares traded.

IDO is engaged in the design, development and marketing of devices for the homeland security and loss prevention markets for use in security screening to detect metallic objects concealed on or in footwear, ankles and feet through the use of electro-magnetic fields. These devices were designed specifically for applications in the security screening to complement the current methods for the detection of metallic items during security screenings and at security checkpoints in venues such as airports, prisons, schools, stadiums and other public locations and other venues requiring individual security screening IDO's sole commercial product, "MagShoe" has been issued one patent by the United States Patent and Trademark Office in November 2005 covering various aspects of its unique technology and there is one patent application pending in Israel. On Dec. 6th 2007, the company announced that the MagShoe(TM) was featured in a BBC London News Report on anti-Terror technology at the ISNR2007 London Exhibition and US Department of Homeland Security (DHS) Science & Technology Stakeholders Conference.

----------------------------------------------------------
    
Chat real-time with other investors about this SFSH news release,
by clicking this link: http://www.stockwire.com/SFSH

To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=SFSH

SinoFresh HealthCare, Inc. (OTCBB: SFSH) up 11.1% on 459,000 shares traded.

SinoFresh HealthCare, Inc. is a developer and marketer of therapies to treat inflammatory and infectious diseases of the upper respiratory system. On Dec. 6th 2007, the company was pleased to announce up-coming human clinical trials to be conducted under the direction of the University of Chicago, School of Medicine. This study follows an earlier study conducted under the direction of Dr. Barry Kreisiwirth at the Public Health Research Institute at the International Center for Public Health where the following conclusions were reported: "These initial killing experiments using SinoFresh Nasal Spray each show virtual contact killing of the well characterized community acquired Methicillin Resistant Staphylococcus Aureur strain MW2 had a complete killing activity within 30 seconds in the presence and absence of mucin and at a high bacterial concentration.".

--------------------------------------------------

About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.

The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.

Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.

As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.

While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at www.sec.gov and/or the National Association of Securities Dealers (NASDAQ) at www.NASDAQ.com. The NASDAQ has published information on how to invest carefully at its web site.

Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml

Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.

From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com.
 
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We often receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares into the open market.

While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .

The Stockwire Group .
512.358.8440 .
info@stockwire.com .